235 related articles for article (PubMed ID: 24256090)
1. Investigating miscibility and molecular mobility of nifedipine-PVP amorphous solid dispersions using solid-state NMR spectroscopy.
Yuan X; Sperger D; Munson EJ
Mol Pharm; 2014 Jan; 11(1):329-37. PubMed ID: 24256090
[TBL] [Abstract][Full Text] [Related]
2. Miscibility of nifedipine and hydrophilic polymers as measured by (1)H-NMR spin-lattice relaxation.
Aso Y; Yoshioka S; Miyazaki T; Kawanishi T; Tanaka K; Kitamura S; Takakura A; Hayashi T; Muranushi N
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1227-31. PubMed ID: 17666850
[TBL] [Abstract][Full Text] [Related]
3. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.
Aso Y; Yoshioka S; Kojima S
J Pharm Sci; 2004 Feb; 93(2):384-91. PubMed ID: 14705195
[TBL] [Abstract][Full Text] [Related]
4. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
[TBL] [Abstract][Full Text] [Related]
6. Phase behavior of poly(vinylpyrrolidone) containing amorphous solid dispersions in the presence of moisture.
Rumondor AC; Marsac PJ; Stanford LA; Taylor LS
Mol Pharm; 2009; 6(5):1492-505. PubMed ID: 19634917
[TBL] [Abstract][Full Text] [Related]
7. Molecular mobility of nifedipine-PVP and phenobarbital-PVP solid dispersions as measured by 13C-NMR spin-lattice relaxation time.
Aso Y; Yoshioka S
J Pharm Sci; 2006 Feb; 95(2):318-25. PubMed ID: 16372315
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of 19F-NMR for assessing the molecular mobility of flufenamic acid in solid dispersions.
Aso Y; Yoshioka S; Miyazaki T; Kawanishi T
Chem Pharm Bull (Tokyo); 2009 Jan; 57(1):61-4. PubMed ID: 19122317
[TBL] [Abstract][Full Text] [Related]
10. The role of polymer concentration on the molecular mobility and physical stability of nifedipine solid dispersions.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2015 May; 12(5):1477-84. PubMed ID: 25894099
[TBL] [Abstract][Full Text] [Related]
11. Miscibility of Amorphous Solid Dispersions: A Rheological and Solid-State NMR Spectroscopy Study.
Song S; Xu J; Chen Z; Sun CC; Munson EJ; Siegel RA
J Pharm Sci; 2024 May; ():. PubMed ID: 38796157
[TBL] [Abstract][Full Text] [Related]
12. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
Paudel A; Nies E; Van den Mooter G
Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
[TBL] [Abstract][Full Text] [Related]
13. Investigation of Phase Mixing in Amorphous Solid Dispersions of AMG 517 in HPMC-AS Using DSC, Solid-State NMR, and Solution Calorimetry.
Calahan JL; Azali SC; Munson EJ; Nagapudi K
Mol Pharm; 2015 Nov; 12(11):4115-23. PubMed ID: 26457879
[TBL] [Abstract][Full Text] [Related]
14. Effect of drug-polymer interactions on the aqueous solubility of milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Shah S; Moghul H; Al-Saden N; Bari F
Int J Pharm; 2013 Mar; 446(1-2):100-5. PubMed ID: 23410988
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
16. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
17. Impact of Drug-Polymer Miscibility on Enthalpy Relaxation of Irbesartan Amorphous Solid Dispersions.
Dalsania S; Sharma J; Munjal B; Bansal AK
Pharm Res; 2018 Jan; 35(2):29. PubMed ID: 29368174
[TBL] [Abstract][Full Text] [Related]
18. Application of Solid-State NMR Relaxometry for Characterization and Formulation Optimization of Grinding-Induced Drug Nanoparticle.
Ueda K; Higashi K; Moribe K
Mol Pharm; 2016 Mar; 13(3):852-62. PubMed ID: 26855230
[TBL] [Abstract][Full Text] [Related]
19. Rheology Guided Rational Selection of Processing Temperature To Prepare Copovidone-Nifedipine Amorphous Solid Dispersions via Hot Melt Extrusion (HME).
Yang F; Su Y; Zhang J; DiNunzio J; Leone A; Huang C; Brown CD
Mol Pharm; 2016 Oct; 13(10):3494-3505. PubMed ID: 27602878
[TBL] [Abstract][Full Text] [Related]
20. Implications of Drug-Polymer Interactions on Time-Temperature-Transformation: A Tool to Assess the Crystallization Propensity in Amorphous Solid Dispersions.
Lalge R; Kumar NSK; Suryanarayanan R
Mol Pharm; 2023 Mar; 20(3):1806-1817. PubMed ID: 36744878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]